The prevalence and associated risks of concurrent use of cholinestrerase inhibitors, antipsychotic and/or anticholinergic medications in patients with alzheimer's disease

dc.contributor.advisorMaxwell, Colleen J.
dc.contributor.authorSupina, Alison Lorraine
dc.date.accessioned2017-12-18T21:55:27Z
dc.date.available2017-12-18T21:55:27Z
dc.date.issued2008
dc.descriptionBibliography: p. 180-204en
dc.format.extentxiii, 240 leaves : ill. ; 30 cm.en
dc.identifier.citationSupina, A. L. (2008). The prevalence and associated risks of concurrent use of cholinestrerase inhibitors, antipsychotic and/or anticholinergic medications in patients with alzheimer's disease (Doctoral thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca. doi:10.11575/PRISM/2874en_US
dc.identifier.doihttp://dx.doi.org/10.11575/PRISM/2874
dc.identifier.urihttp://hdl.handle.net/1880/103875
dc.language.isoeng
dc.publisher.institutionUniversity of Calgaryen
dc.publisher.placeCalgaryen
dc.rightsUniversity of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission.
dc.titleThe prevalence and associated risks of concurrent use of cholinestrerase inhibitors, antipsychotic and/or anticholinergic medications in patients with alzheimer's disease
dc.typedoctoral thesis
thesis.degree.disciplineCommunity Health Sciences
thesis.degree.grantorUniversity of Calgary
thesis.degree.nameDoctor of Philosophy (PhD)
ucalgary.thesis.accessionTheses Collection 58.002:Box 1827 520708990
ucalgary.thesis.notesUARCen
ucalgary.thesis.uarcreleaseyen
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ucalgary_2008_supina_alison lorraine_559982.pdf
Size:
11.54 MB
Format:
Adobe Portable Document Format
Description:
Thesis
Collections